[从神经学的角度来看,和精神性非发作之间的区别]
1Department of Neurology, International University of Health and Welfare.
Brain and nerve = Shinkei kenkyu no shinpo
|June 16, 2025
概括
精神性非发作 (PNES) 模仿,但源于心理因素. 像认知行为疗法这样的有效治疗方法得到越来越多的支持,为面临诊断和护理挑战的患者提供希望.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 精神病体医学是一种精神病体医学.
背景情况:
- 精神性非发作 (PNES) 伴有类似发作的发作,但是由心理因素引发的,而不是.
- 在DSM-5中,PNES被归类为功能神经症状或转化障碍.
- 虽然PNES的发病率低于,但它影响了专门的护理机构中少数患者.
研究的目的:
- 为提供心理非发作 (PNES) 的概述.
- 突出与PNES相关的诊断挑战和医疗负担.
- 讨论关于有效PNES治疗的越来越多的证据.
主要方法:
- 关于PNES流行,分类和治疗疗效的文献综述.
- 对被诊断为PNES患者的医疗保健资源利用率的分析.
- 对治疗干预措施的当前证据的综合.
主要成果:
- 普尼斯经常被误诊或延迟诊断,导致大量的医疗保健费用.
- 患有PNES的患者经历了诊断程序和治疗的重大负担.
- 认知行为和神经行为疗法在PNES管理中的有效性的证据正在积累.
结论:
- PNES代表了一种独特的神经疾病,具有精神病学基础.
- 改进的诊断策略和可获得的,基于证据的治疗方法对于管理PNES至关重要.
- 对PNES的最佳治疗方法进行进一步的研究是有必要的,以减少患者的负担和改善结果.
更多相关视频
09:00Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
Published on: April 15, 2015
12.4K
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.6K
相关概念视频
Seizures: Classification
620
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
620
Epilepsy and Seizures: Overview
297
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
297
Overview of Synapses
3.1K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
3.1K
Antiepileptic Drugs: Glutamate Antagonists
528
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
528
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
463
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
463
Antiepileptic Drugs: GABAergic Pathway Potentiators
685
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
685
